Physician profile
Vasanth M Vishwanath
NPI 1891809968
$14,342.08
in general payments reported to CMS, 2019-2025
22 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $95.32 · 2021: $98.28 · 2022: $125 · 2023: $109 · 2024: $640 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $919.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,840.66 | 2019-2024 | |
| Abbvie INC. | $206.82 | 2019-2023 | Liletta |
| Coopersurgical, INC. | $156.08 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $153.56 | 2019-2024 | Thinprep 2000 Processor |
| Gilead Sciences, INC. | $125.35 | 2025 | Yeztugo |
| Aspira Women'S Health INC | $116.44 | 2019 | |
| Mayne Pharma Commercial LLC | $115.45 | 2023-2025 | |
| Optumhealth Care Solutions, LLC | $111.49 | 2023-2024 | Eitan Medical, Vivify Health Care Team Portal 001, Vivify Health Care Team Portal |
| Daiichi Sankyo INC. | $109.85 | 2019-2024 | Injectafer |
| Shield Therapeutics INC | $61.67 | 2024 | |
| Lupin INC. | $53.57 | 2019-2020 | |
| Astellas Pharma US INC | $44.10 | 2024 | Veozah |
| Organon LLC | $43.12 | 2024-2025 | Nexplanon |
| Evofem Biosciences, INC. | $37.31 | 2024 | |
| Becton, Dickinson and Company | $31.92 | 2022-2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $26.58 | 2019 | |
| Merck Sharp & Dohme LLC | $25.01 | 2019 | |
| Therapeuticsmd, INC. | $21.50 | 2022 | |
| Sage Therapeutics, LLC | $18.89 | 2024 | |
| Amag Pharmaceuticals, INC. | $15.75 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.83 | 2019 | |
| Allergan, INC. | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasanth Vishwanath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.